Orphan Diseases Market Report

Global and Region Orphan Diseases Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：206
  • REPORT CODE：GMM960547
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Orphan Diseases market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Orphan Diseasesmarket, defines the market attractiveness level of Orphan Diseases market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Orphan Diseases industry, describes the types of Orphan Diseases market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orphan Diseases market and the development prospects and opportunities of Orphan Diseases industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orphan Diseases market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Roche

    • Sanofi

    • Merck

    • Alexion

    • Abbvie

    • Novartis

    • Celgene

    • Pfizer

    • Bristol-Myers Squibb

    • Vertex Pharmaceuticals

    By Type:

    • Autoimmune Disorders

    • Genetic Disorders

    • Blood Disorders

    • Cancer

    • Growth Disorder

    • Cardiovascular Diseases

    • Neurological Disorders

    • Respiratory Disorders

    • Digestive Disorders

    • Eye Disorders

    By End-User:

    • Hospitals And Clinics

    • Research Laboratories

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Orphan Diseases Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Orphan Diseases Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Orphan Diseases Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Orphan Diseases Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Orphan Diseases Market Analysis and Outlook to 2022

    • 7.1 Global Orphan Diseases Consumption (2017-2022)

    • 7.2 United States Orphan Diseases Consumption (2017-2022)

    • 7.3 Europe Orphan Diseases Consumption (2017-2022)

    • 7.4 China Orphan Diseases Consumption (2017-2022)

    • 7.5 Japan Orphan Diseases Consumption (2017-2022)

    • 7.6 India Orphan Diseases Consumption (2017-2022)

    • 7.7 South Korea Orphan Diseases Consumption (2017-2022)

    8 Region and Country-wise Orphan Diseases Market Analysis and Outlook to 2028

    • 8.1 Global Orphan Diseases Consumption Forecast (2022-2028)

    • 8.2 United States Orphan Diseases Consumption Forecast (2022-2028)

    • 8.3 Europe Orphan Diseases Consumption Forecast (2022-2028)

    • 8.4 China Orphan Diseases Consumption Forecast (2022-2028)

    • 8.5 Japan Orphan Diseases Consumption Forecast (2022-2028)

    • 8.6 India Orphan Diseases Consumption Forecast (2022-2028)

    • 8.7 South Korea Orphan Diseases Consumption Forecast (2022-2028)

    9 Global Orphan Diseases Market Outlook by Types and Applications to 2022

    • 9.1 Global Orphan Diseases Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Genetic Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Growth Disorder Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Respiratory Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Digestive Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Eye Disorders Consumption and Growth Rate (2017-2022)

    • 9.2 Global Orphan Diseases Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals And Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Laboratories Consumption and Growth Rate (2017-2022)

    10 Global Orphan Diseases Market Outlook by Types and Applications to 2028

    • 10.1 Global Orphan Diseases Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Growth Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Eye Disorders Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Orphan Diseases Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals And Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

    11 Global Orphan Diseases Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Orphan Diseases Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Orphan Diseases Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Orphan Diseases Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Orphan Diseases Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Orphan Diseases Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Orphan Diseases Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Orphan Diseases Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Orphan Diseases Product and Service

    • 14.5 Alexion

      • 14.5.1 Alexion Company Details

      • 14.5.2 Alexion Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Alexion Orphan Diseases Product and Service

    • 14.6 Abbvie

      • 14.6.1 Abbvie Company Details

      • 14.6.2 Abbvie Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Abbvie Orphan Diseases Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Orphan Diseases Product and Service

    • 14.8 Celgene

      • 14.8.1 Celgene Company Details

      • 14.8.2 Celgene Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Celgene Orphan Diseases Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Orphan Diseases Product and Service

    • 14.10 Bristol-Myers Squibb

      • 14.10.1 Bristol-Myers Squibb Company Details

      • 14.10.2 Bristol-Myers Squibb Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb Orphan Diseases Product and Service

    • 14.11 Vertex Pharmaceuticals

      • 14.11.1 Vertex Pharmaceuticals Company Details

      • 14.11.2 Vertex Pharmaceuticals Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Vertex Pharmaceuticals Orphan Diseases Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Orphan Diseases

    • Figure Orphan Diseases Picture

    • Table Global Orphan Diseases Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orphan Diseases Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orphan Diseases Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Orphan Diseases Consumption by Country (2017-2022)

    • Figure United States Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Table Europe Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Figure China Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Figure Japan Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Figure India Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Figure South Korea Orphan Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Orphan Diseases Consumption Forecast by Country (2022-2028)

    • Figure United States Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Genetic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Digestive Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Eye Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals And Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eye Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals And Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Orphan Diseases Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Orphan Diseases Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Orphan Diseases Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Orphan Diseases Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Orphan Diseases Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Orphan Diseases Product and Service

    • Table Alexion (Foundation Year, Company Profile and etc.)

    • Table Alexion Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Orphan Diseases Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Orphan Diseases Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Orphan Diseases Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Orphan Diseases Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Orphan Diseases Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Orphan Diseases Product and Service

    • Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Vertex Pharmaceuticals Orphan Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vertex Pharmaceuticals Orphan Diseases Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US